OE19

Export PDF

Strain Information

Cell Line

OE19

Cat. NO.

NM-YH07

Model Description

The cell line OE19, also known as JROECL19, was established in 1993 from an adenocarcinoma of gastric cardia/oesophageal gastric junction of a 72 year old male patient.

Strain State

Validation of tumorigenic capacity completed

Validation Data

I. Characterization of in vivo growth kinetics

The OE19 cells were subcutaneously inoculated into the M-NSG mice (NM-NSG-001) and huPBMC-(M-NSG) mice (NM-NSG-015).

image.png

Figure 1. Tumor growth curve of OE19 xenograft model (n=6)

image.png

Figure 2. Body weight change of OE19 xenograft model (n=6）

*Wild-type cell lines are not for sale, and only applied to construction of tumor bearing mice and in-vivo efficacy studies.

Related Strain(s)

You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more